ArticleDiagnostics (Basel, Switzerland)2021

Prognostic Markers of Survival among Japanese Patients with Anaplastic Lymphoma Kinase-Positive Non-Small-Cell Lung Cancer Receiving First-Line Alectinib.

Takayuki Takeda et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.